• about

iCellate is a Swedish, privately owned, stock company founded in 2011 and based in Hagalund in Stockholm. iCellate develops products in the field of cancer research and detection. iCellate is based on research from the Karolinska Institute in collaboration with the Karolinska University Hospital and the Royal Institute of Technology in Stockholm.

The company is both a UIC (Uppsala Innovation Center) and a STING alumnus and has through the years received many awards from both scientific institutions and private companies.